Tiyun Han

机构：CTI BioPharma (Italy) · ORCID：0000-0001-5956-2188

发表论文 32 篇 · 总被引 317 次 · h-index 9

代表论文

• Optimization of Lipid Nanoformulations for Effective mRNA Delivery (2022 · International Journal of Nanomedicine · 被引 50)
• Dihydromyricetin alleviates inflammatory bowel disease associated intestinal fibrosis by inducing autophagy through the PI3K/AKT/mTOR signaling pathway (2023 · Naunyn-Schmiedeberg s Archives of Pharmacology · 被引 16)
• High‐dose amoxicillin‐proton pump inhibitor dual therapy as first‐line treatment for Helicobacter pylori infection in Northwest China: A prospective, randomised controlled trial (2022 · British Journal of Clinical Pharmacology · 被引 13)
• Exploration of mRNA nanoparticles based on DOTAP through optimization of the helper lipids (2023 · Biotechnology Journal · 被引 12)
• Large-scale transcript variants dictate neoepitopes for cancer immunotherapy (2025 · Science Advances · 被引 11)
• The mRNA vaccine expressing fused structural protein of PRRSV protects piglets against PRRSV challenge (2025 · Veterinary Microbiology · 被引 8)